{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:50:22Z","timestamp":1791298222359,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s12185-010-0746-y","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T10:57:38Z","timestamp":1294311458000},"page":"66-73","source":"Crossref","is-referenced-by-count":32,"title":["Analysis of bacteremia\/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group"],"prefix":"10.1007","volume":"93","author":[{"given":"Minoru","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobu","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Kito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shigeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,7]]},"reference":[{"key":"746_CR1","first-page":"57","volume-title":"Textbook of febrile neutropenia","author":"WV Kern","year":"2001","unstructured":"Kern WV. Current epidemiology of infections in neutropenic cancer patients. In: Rolston KVI, Rubenstein EB, editors. Textbook of febrile neutropenia. London: Martin Dunitz Ltd; 2001. p. 57\u201390."},{"key":"746_CR2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36:1103\u201310.","journal-title":"Clin Infect Dis"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01700277","volume":"69","author":"H Link","year":"1994","unstructured":"Link H, Maschmeyer G, Meyer P, et al. Interventional antimicrobial therapy in febrile neutropenic patients. Ann Hematol. 1994;69:231\u201343.","journal-title":"Ann Hematol"},{"key":"746_CR4","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/1097-0142(19940501)73:9<2296::AID-CNCR2820730910>3.0.CO;2-7","volume":"73","author":"G Maschmeyer","year":"1994","unstructured":"Maschmeyer G, Link H, Hiddemann W, et al. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer. 1994;73:2296\u2013304.","journal-title":"Cancer"},{"key":"746_CR5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1378\/chest.114.2.444","volume":"114","author":"S Ewig","year":"1998","unstructured":"Ewig S, Glasmacher A, Ulrich B, et al. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest. 1998;114:444\u201351.","journal-title":"Chest"},{"key":"746_CR6","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.ijid.2009.02.021","volume":"14","author":"E Lech-Maranda","year":"2010","unstructured":"Lech-Maranda E, Seweryn M, Giebel S, et al. Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG). Int J Infect Dis. 2010;14:e132\u201340.","journal-title":"Int J Infect Dis"},{"key":"746_CR7","first-page":"261","volume":"70","author":"M Yoshida","year":"1999","unstructured":"Yoshida M, Tsubaki K, Kobayashi T, et al. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. Int J Hematol. 1999;70:261\u20137.","journal-title":"Int J Hematol"},{"key":"746_CR8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/161.3.381","volume":"161","author":"WT Hughes","year":"1990","unstructured":"Hughes WT, Armstrong D, Bodey GP, et al. From the Infectious Disease Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990;161:381\u201396.","journal-title":"J Infect Dis"},{"key":"746_CR9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","volume":"25","author":"WT Hughes","year":"1997","unstructured":"Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551\u201373.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"746_CR10","first-page":"S9","volume":"68","author":"T Masaoka","year":"1998","unstructured":"Masaoka T. Management of fever of unknown origin in the neutropenic patient: the Japanese experience. Int J Hematol. 1998;68(Suppl 1):S9\u201311.","journal-title":"Int J Hematol"},{"key":"746_CR11","first-page":"703","volume":"51","author":"M Yoshida","year":"2003","unstructured":"Yoshida M, Akiyama N, Takahashi M, et al. Management of infectious complications in patients with acute leukemia during chemotherapy\u2014a questionnaire analysis by the Japan Adult Leukemia Study Group. Jpn J Chemother. 2003;51:703\u201310. (in Japanese).","journal-title":"Jpn J Chemother"},{"issue":"Suppl 1","key":"746_CR12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/383044","volume":"39","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Ohno R. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey. Clin Infect Dis. 2004;39(Suppl 1):S11\u20134.","journal-title":"Clin Infect Dis"},{"key":"746_CR13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730\u201351.","journal-title":"Clin Infect Dis"},{"key":"746_CR14","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","volume":"18","author":"H Ozer","year":"2000","unstructured":"Ozer H, Armitage JO, Bennett CL, et al. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol. 2000;18:3558\u201385.","journal-title":"J Clin Oncol"},{"key":"746_CR15","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1002\/1097-0142(19930615)71:12<3888::AID-CNCR2820711216>3.0.CO;2-G","volume":"71","author":"R Ohno","year":"1993","unstructured":"Ohno R, Kobayashi T, Tanimoto M, et al. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. JALSG-AML87. Cancer. 1993;71:3888\u201395.","journal-title":"Cancer"},{"key":"746_CR16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/JCO.1996.14.1.204","volume":"14","author":"T Kobayashi","year":"1996","unstructured":"Kobayashi T, Miyawaki S, Tanimoto M, et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance\/intensification therapy in adult acute myeloid leukemia. J Clin Oncol. 1996;14:204\u201313.","journal-title":"J Clin Oncol"},{"key":"746_CR17","first-page":"97","volume":"70","author":"S Miyawaki","year":"1999","unstructured":"Miyawaki S, Tanimoto M, Kobayashi T, et al. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group. Int J Hematol. 1999;70:97\u2013104.","journal-title":"Int J Hematol"},{"key":"746_CR18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12185-009-0480-5","volume":"91","author":"S Ohtake","year":"2010","unstructured":"Ohtake S, Miyawaki S, Kiyoi H, et al. Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study. Int J Hematol. 2010;91:276\u201383.","journal-title":"Int J Hematol"},{"key":"746_CR19","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/cncr.21493","volume":"104","author":"S Miyawaki","year":"2005","unstructured":"Miyawaki S, Sakamaki H, Ohtake S, et al. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML97 study. Cancer. 2005;104:2726\u201334.","journal-title":"Cancer"},{"key":"746_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2141.1991.tb07948.x","volume":"77","author":"T Motoji","year":"1991","unstructured":"Motoji T, Watanabe M, Uzumaki H, et al. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay. Br J Haematol. 1991;77:54\u20139.","journal-title":"Br J Haematol"},{"key":"746_CR21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","volume":"142","author":"A Gafter-Gvili","year":"2005","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 2005;142:979\u201395.","journal-title":"Ann Intern Med"},{"key":"746_CR22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/1097-0142(20001001)89:7<1611::AID-CNCR27>3.0.CO;2-B","volume":"89","author":"Y Kanda","year":"2000","unstructured":"Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Cancer. 2000;89:1611\u201325.","journal-title":"Cancer"},{"key":"746_CR23","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1200\/JCO.2003.04.052","volume":"21","author":"A Glasmacher","year":"2003","unstructured":"Glasmacher A, Prentice A, Gorschluter M, et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. J Clin Oncol. 2003;21:4615\u201326.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"746_CR24","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/383046","volume":"39","author":"K Tamura","year":"2004","unstructured":"Tamura K, Imajo K, Akiyama N, et al. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Clin Infect Dis. 2004;39(Suppl 1):S15\u201324.","journal-title":"Clin Infect Dis"},{"key":"746_CR25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358\u201366.","journal-title":"Clin Infect Dis"},{"key":"746_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","volume":"79","author":"TF Patterson","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis, disease spectrum, treatment practices, and outcomes. Medicine. 2000;79:250\u201360.","journal-title":"Medicine"},{"key":"746_CR27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","volume":"4","author":"MASH Mennink-Kersten","year":"2004","unstructured":"Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis. 2004;4:349\u201357.","journal-title":"Lancet Infect Dis"},{"key":"746_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(95)91152-9","volume":"345","author":"T Obayashi","year":"1995","unstructured":"Obayashi T, Yoshida M, Mori T, et al. Plasma (1\u21923)-\u03b2-d-glucan determination in the diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17\u201320.","journal-title":"Lancet"},{"key":"746_CR29","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1086\/323337","volume":"33","author":"M Kami","year":"2001","unstructured":"Kami M, Fukui T, Ogawa S, et al. Real-time polymerase chain reaction using blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis. 2001;33:1504\u201312.","journal-title":"Clin Infect Dis"},{"key":"746_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","volume":"15","author":"D Caillot","year":"1997","unstructured":"Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15:139\u201347.","journal-title":"J Clin Oncol"},{"key":"746_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408\u201315.","journal-title":"N Engl J Med"},{"key":"746_CR32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of Aspergillosis: clinical practice guidelines of the Infectious Disease Society of America. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0746-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0746-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T12:46:53Z","timestamp":1559911613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0746-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}